Position in CPRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,564,675
+$249,593 QoQ
Shares Held
305,520
-2.5% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. CPRX ranks #31 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,564,675 | 305,520 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,315,082 | 313,414 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,506,949 | 330,302 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $7,140,992 | 329,078 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,531,274 | 310,568 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $6,518,118 | 312,320 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $6,189,995 | 311,368 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,015,181 | 323,769 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,988,646 | 312,964 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,856,762 | 288,921 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,415,654 | 292,186 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,864,833 | 287,562 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,655,348 | 280,781 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,916,742 | 264,341 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,314,001 | 258,301 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $776,595 | 110,784 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,060,730 | 127,953 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,005,229 | 148,483 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $792,731 | 149,572 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $847,498 | 147,391 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $551,107 | 119,546 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $421,795 | 126,286 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $353,893 | 119,156 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $628,139 | 135,961 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $486,101 | 126,260 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||